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Abstract.  In a number of systems phosphorylation of 
the regulatory light chain (RMLC) of myosin regulates 
the activity of myosin. In smooth muscle and ver- 
tebrate nonmuscle systems RMLC phosphorylation is 
required for contractile activity. In Dictyostelium dis- 
coideum phosphorylation of the RMLC regulates both 
ATPase activity and motor function. We have deter- 
mined the site of phosphorylation on the Dictyostelium 
RMLC and used site-directed mutagenesis to replace 
the phosphorylated serine with an alanine. The mutant 
light chain was then expressed in RMLC null Dic- 
tyostelium cells (mLCR-) from an actin promoter on 
an integrating vector. The mutant RMLC was 
expressed at high levels and associated with the myo- 
sin heavy chain. RMLC bearing a  ser13ala  substitution 
was not phosphorylated in vitro by purified myosin 
light chain kinase, nor could phosphate be detected on 
the mutant RMLC in vivo. The mutant myosin had re- 
duced actin-activated ATPase activity, comparable to 
fully dephosphorylated myosin. Unexpectedly, expres- 
sion of the mutant RMLC rescued the primary pheno- 
typic defects of the mlcR- ceils to the same extent as 
did expression of wild-type RMLC.  These results sug- 
gest that while phosphorylation of the Dictyostelium 
RMLC appears to be tightly regulated in vivo, it is 
not essential for myosin-dependent cellular functions. 
M 
YOSIN is responsible  for force generation  in cor- 
tical  tension  (Clarke  and Spudich,  1974; Fukui 
and Yumura,  1986; Pasternak et al.,  1989), cell 
motility, eytokinesis (Mabuchi and Okuno,  1977; Kiehart et 
al.,  1982; DeLozanne and  Spudich,  1987; Knecht and 
Loomis,  1987; Manstein et al.,  1989; Karess et al.,  1991; 
Pollenz et al.,  1992), morphogenesis (Knecht and Loomis, 
1987; DeLozanne and Spudich,  1987; Pollenz et al., 1992), 
phagoeytosis (Stendahl et al., 1980; Fukui et al., 1990), and 
membrane receptor capping (Pasternak et al., 1989; Pollenz 
et al.,  1992). In the cellular slime mold Dictyostelium dis- 
coideum, myosin II is  localized  in the contractile ring of 
dividing cells and in the trailing end of  loeomoting cells (Yu- 
mura and Fukui,  1985). 
Dictyostelium myosin H is a hexamer composed of two 
243-kD  heavy chains,  two  18-kD regulatory light chains, 
and two 16-kD essential light chains. The molecule consists 
of two  structural  and  functional  domains:  an  a-helical 
coiled-coil  rod-like  tail responsible  for filament assembly 
(Kuczmarski and Spudich,  1980; DeLozanne and Spudich, 
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1987; Egelhoff et al.,  1991), and a globular head that con- 
tains the light chains, actin and ATP-binding sites, and ATP- 
ase activity (C6t6 and Bukiejko, 1987; Warrick and Spudich, 
1987; Vibert and Cohen,  1988; Korn and Hammer, 1988; 
Rayment et al.,  1993). Like muscle myosin, Dictyosteliura 
myosin II can form bipolar thick filaments in vivo (Yumura 
and Fukui,  1985; Fukui,  1990) and in vitro (Pasternak  et 
al.,  1989). 
The activity of Dictyostelium myosin is  regulated by a 
myosin-linked process and exhibits properties of assembly 
and activation distinct from smooth muscle and vertebrate 
nonmuscle myosin. Assembly of Dictyostelium myosin into 
filaments is regulated by phosphorylation at three sites in the 
carboxyl-terminal 34-kD of the heavy chain (C6t6 and Buk- 
iejko, 1987; Vaillancourt et al., 1988; Luck-Vielmetter et al., 
1990) which produces a bending of the tail (Claviez et al., 
1982; Kuczmarsld et al.,  1987; Vaillancourt et al.,  1988; 
Lock-Vielmetter et al., 1990; Truong et ai., 1992). In con- 
trast, bending of the tail of smooth muscle and vertebrate 
nonmuscle myosin is regulated by light chain phosphoryla- 
tion. In these systems phosphorylation  of regulatory myosin 
light  chain  (RMLC) ~ by  a  Ca2÷-calmodulin dependent 
MLCK stimulates both assembly and actin-activated ATPase 
(Suzuki et al., 1978; Somlyo and Somlyo, 1981; Kamm and 
1. Abbreviations used in this paper:  MHC,  myosin heavy chain; RMLC, 
regulatory myosin light chain. 
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while in Dictyostelium phosphorylation of the RMLC regu- 
lates only enzymatic activity (Griflith et al.,  1987). 
The Dictyostelium RMLC is phosphorylated in vivo (Kucz- 
marski and Spudich,  1980) by a specific Ca2+-calmodulin - 
independent myosin light chain kinase in response to cTclic 
AMP (Berlot et al.,  1985; Griflith et al.,  1987; Berlot et al., 
1987).  RMLC  phosphorylation  occurs  only  on  serine 
residues (Berlot et al.,  1987). In vitro, RMLC phosphoryla- 
tion increases the actin-activated  Mg  2÷ ATPase activity of 
myosin (Griflith et al.,  1987;  Trybus,  1989) and stimulates 
motor function as assayed by movement of actin filaments in 
vitro (Griflith et al., 1987). Phosphorylation of purified Dic- 
tyostelium myosin by cloned Dictyostelium MLCK stimu- 
lates actin-activated ATPase three- to sixfold and nearly dou- 
bles the rate of actin filament movement in vitro (Uyeda and 
Spudich, 1993; Ruppel et al., 1994). RMLC dephosphoryla- 
tion restores the activity to a basal level (Kuczmarski and 
Pagone,  1986; Griflith et al.,  1987). 
Chen et al. (1994) have produced and characterized RMLC 
null cell lines, in which the single ruleR gene was disrupted 
by homologous recombination.  The  ability to reintroduce 
light chains into a null background provides the opportunity 
to assess the in vivo consequences of a variety of RMLC mu- 
tations.  We have employed this  system to  investigate  the 
function of RMLC phosphorylation in living cells. We deter- 
mined the site of RMLC phosphorylation by purified, cloned 
Dictyostelium MLCK (Tan and Spudich, 1991) and used site- 
directed mutagenesis to eliminate that phosphorylation site. 
When the mutant RMLC is expressed in Dictyostelium it as- 
sociates with the myosin heavy chain (MHC). Despite its in- 
ability to be phosphorylated in vivo, the phosphorylation site 
mutant rescues the cytokinesis and developmental defects of 
the RMLC null mutants.  Biochemically the mutant myosin 
exhibits '~30% of the actin activated MgATPase activity of 
purified wild-type myosin. These results suggest that while 
phosphorylation of the Dictyostelium RMLC appears to be 
tightly  regulated in vivo,  it is not essential  for completing 
cytokinesis or morphogenesis. 
Materials and Methods 
Chemicals were pumhased from Sigma Chem. Co. (St. Louis, MO) unless 
otherwise noted.  Potassium iodide, urea, dithiothreitol, glycine, and mag- 
nesium chloride were from Research Organics, Inc. (Cleveland, OH). Mer- 
captcethanol, glycerol, methanol, and sulfuric acid were from Mailinkrodt 
(Paris, KY).  Sodium dodecyl  sulfate was from Pierce Chem. Co.  (Rock- 
ford,  IL).  Acrylamide and Coomassie were from Bio-Rad  Labs.  (Rich- 
mond,  CA).  [32p]-ATP (>3,000  Ci/mmol) was  from Amersham Corp. 
(Arlington Heights,  IL).  Restriction enzymes and "[hq polymerase were 
from Boehringer Mannheim Corp.  (Indianapolis,  IN). 
Cell Culture and Transformations 
Dictyostelium  discoideum  RMLC  null cells (strains 43E9,  45E12,  and 
GllDS) have been previously  described (Chen et ai.,  1994). RMLC null 
cells ofail three strains were transfected with 5-/~g  plasmid DNA by electro- 
poration (Howard et ai.,  1988) using a BioRad gene pulser at settings 3/~F, 
1.3 kV, 25 Ohm, 1 ms time constant. One day after electroporation,  media 
was replaced with HL5 containing 10 t~g/ml G418 (Geneticin; Sigma). To 
establish  cell lines, transformants were cloned by plating on Klebsiella aero- 
genes lawns and cells from well-isolated  plaques were grown in HL5. 
Oligonucleotide-directed  Mutagenesis 
A full-length RMLC cDNA (Tafuri et al., 1989) in pBluescript (Stratagene 
Inc., La Jolla,  CA) was used as the template for PCR-based  mutagenesis. 
PCR using synthetic primer pair A (5'-GTAAAACGACGC~CAGT-Y) and 
B (5'-CTACAGAGC~CTCTTCTCTG-3~ produced a 5' product where the 
codon for Serl3 ('ICA) was changed to Ala (GCC) generating a novel StuI 
restriction site (see  Fig.  2  a).  PCR using primer pair C  (5'-CAGAGA- 
AGAGC~CTCTGTAG-3~ and D (5'-AACAGCTATGACCATG-39  produced 
a 3' product with the same nucleotide substitutions and StuI site. The 5' and 
3' PCR products were digested  with PstI and StuI or StuI  and Baml-II, 
respectively, and gel purified.  The fragments were ligated together into Pstl 
and BamHI-digested pBhiescript vector and sequenced to assure that no ad- 
ditional mutations were introduced by the Taq polymerase.  These manipula- 
tions restored the reading frame and produced  the desired Ser13 to Alal3 
codon change.  The same strategy  was employed to change the codon for 
Serl4 (TCT) to Alal4 (GCT) using primer pairs A and E (5'-AACTAC- 
AGCTGATTCTTCTC-3~ and C and F (5'-GAAGAATCAGCTGTAGTT-3~ 
which introduce a novel PvuII site.  PCR using primer pair C and G (5'- 
GGGATCCTTATAAATCTTCTTCTGAAATTAATTTTTGTTCTTTT- 
TTACTGAAGAGAG-3')  inserted 30 nucleotides encoding a 10-amino acid 
epitope of the myc oncogene (EQKLISEEDL,  Evan et al.,  1985) immedi- 
ately 5' to the TAA stop codon of the eDNA. 
Vector Construction 
Escherichia coil Expression  Vectors. PCR was used to remove the untrans- 
lated portions of the wild-type  RMLC and $13A RMLC cDNAs for sub- 
cloning into E. coli expression vector pET3d (Novagen Inc., Madison, WI). 
PCR was done using primer pair H (5"TCfo-CCTCAACCAAAAGAAGAT- 
TAAAC-3~ and I (5'-ACTTTATTTTTTACTGAAGAGAGTATT-3')  with the 
wild-type  or $13A eDNA as template.  The PCR products  were subcioned 
in the svnse orientation into the filled-in NdeI site of pET3d, and sequenced. 
These manipulations inserted the eDNA between a T7 promoter and a T7 
terminator and fused  61  nucleotides  encoding a  six-histidine  tag and a 
thrombin cleavage site to the 5' end of the RMLC such that a fusion protein 
was expressed  under control of the T7 promoter. 
Dictyostelium  Expression  Vectors. The methionine initiator codon of 
the Dictyostelium actin 15 gene (Knecht et ai.,  1986) was mutated to a 
BamHI site and the 270-bp BglII-BamHI promoter fragment was subcloned 
into pBhiescript (Pollenz et ai., 1992). A 600-bp BamI-II-HindIH (filled-in) 
fragment of pDNeo2 (gift of A. Ncegel, Max Plank Institute,  Martinsreid, 
Germany) containing the Dictyostelium actin 8 terminator (McKeown and 
Firtel, 1981) was subcloned downstream  of the mutated actin promoter to 
produce pBVIT. The 2-kb XbaI neomycin phosphotransferase  cassette of 
pDNeo2 was subcloned into the HindIII (filled-in) site of pBV17 to produce 
pBORP (see Fig. 3 A). W'fld-type RMLC eDNA, and wild-type and mutant 
myc-tagged RMLC cDNAs were subcloned in the sense orientation  into the 
BamI-II site between the actin promoter and terminator to produce,  respec- 
tively, pBVN519, pBVN5131, pBVN5115, and pBVN5133. 
Protein Preparation 
Recombinant RMLC. The pET3d expression constructs were transformed 
into E. coli BL21(DE3).  This strain produces T7 RNA polymerase in re- 
sponse to IPTG induction.  Bacterial cultures were grown to At00 =  0.8, at 
which time IFIG was added to 0.4 mM and incubated for another 3 h. Cells 
were sonicated in IMAC-5 (20 mM Tris-HC1,  pH 7.9, 0.5 M NaCI,  10% 
glycerol,  1 mM PMSF, 5 mM imidazole).  The lysate was clarified by cen- 
trifugation,  filtered  through a 0.45-/zm membrane (Costar Corp.,  Cam- 
bridge,  MA),  and loaded  on a  His-Bind resin column (Novagen).  His- 
tagged RMLC was eluted with 60% IMAC-200 (IMAC-5 with imidazole 
at 200  raM),  dialyzed  against 20 mM  Tris-HCl,  pH  8.3, lyophilized, 
resuspended to a concentration of 2 mg/ml in thrombin digestion buffer (20 
mM Tris-HCl, pH 8.4, 0.15 M NaCI, 2.5 mM CaC12, 10% glycerol),  and 
digested with human thrombin (Novagen) at a enzyme/substrate ratio of 0.5 
units/mg. 
Myosin.  Myosin was purified  from Dictyostelium cells as described by 
Pollenz et al. (1992) except ammonium sulphate precipitation was avoided 
and a Superose 6 gel filtration column (Pharmacia LKB Nuclear, Gaithers- 
burg, MD) was used in place of S-500 gel filtration.  The concentration of 
myosin was determined using bovine serum albumin (Cohn Fraction V) as 
a standard with the BioRad protein assay. 
Actin. Chicken muscle actin was purified from acetone powder accord- 
ing to Pardce and Spudich (1982). On the day of use, 20 nag iyophilized actin 
was rcsuspended in Buffer A (2 mM Tris-HC1,  pH 8.0, 0.2 mM ATP, 0.2 
mM calcium chloride, 0.5 mM ~-memaptoethanol, 0.005 % sodium azide), 
clarified by centrifugation,  and the concentration was determined by mea- 
suring the A290 and dividing by a correction factor of 0.62 (Uyemura et al., 
1978). 
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of ~2P-labeled  Myosin 
Metabolic labeling was performed using a protocol generously provided by 
Dr. Janet Smith (Stanford University, Palo Alto, CA). Cells were harvested 
at 5  ×  106 cells/mi, washed and grown in phosphate-free FM medium for 
7 h. The cells were then pelleted and resnspended in phosphate-free FM 
medium at 5  x  l0  T eells/ml.  [32P]orthophosphate (100/zCi) was added to 
200-t~l aliquots of cells. The cultures were incubated at room temperature 
for 3 h  with end-over-end rotation.  Labeled cells were harvested and the 
myosin  heavy  chain  immunoprecipitated  using  the  396  MHC-specific 
monoclonal antibody (generously provided by Dr. G. Gerisch, Max Planck 
Institute, Martinsreid, Germany) as described by Berlot et al. (1985). Sam- 
ples were separated by electrophoresis on  15%  polyacrylamide gels and 
transferred to nitrocellulose. 
Electrophoretic Analysis 
SDS-PAGE and immunoblotting was performed as described in Pollenz et 
al. 0992) except anti-RMLC mAb 1A2 was reacted at 1:100 dilution over- 
night, then secondary goat anti-mouse IgG horseradish peroxidase con- 
jugate (Jackson Immunoresearch Labs., Inc., West Grove, PA) was reacted 
at 1:100,000,  and detected by ECL (Amersham). 
Urea-glycerol PAGE was performed with a modification of Perrie and 
Perry (1970). Myosin (1 #g) in storage buffer was boiled in 2x  SDS gel 
sample buffer, cooled, and urea sample buffer added to produce final con- 
centrations of 4.5 M urea,  10.8 mM Tris-HC1, pH 8.6, 86.4 mM glycine, 
0.7 mM EDTA,  0.5 mM DTT.  The separating gel was 7.5%  acrylamide, 
0.28% bisacrylamide, 50% glycerol, 20 mM Tris-HCl,  pH 8.6,  160 mM 
glycine. The stacking gel was 3.5 % acrylamide, 0.13 % bisacrylamide, 50% 
glycerol,  71  mM  Tris-HC1,  pH  6.8.  The  running  buffer was  20  mM 
Tris-HCl, pH 8.6, 160 mM glycine. The samples were run at 4W constant 
power. 
Amino Acid Sequencing 
To determine the site of MLCK phosphorylation the sequences of phos- 
phorylated  and unphosphorylated  RMLC  were  determined.  Thrombin- 
digested  recRMLC  (8  ttg)  was  run on  12%  SDS-PAGE,  transferred to 
PVDF membrane (Problot; Applied Biosystems Inc., Foster City, CA) for 
1.5 hr at 300 mA in 10 mM 3-[eyelohexylamino]-l-propanesulfonic acid 
(CAPS), pH 11.0, 10 % methanol. The membrane was rinsed in Milli-Q wa- 
ter, stained with 0.1% Coomassie Brilliant Blue in 40 % methanol, 1% acetic 
acid, and destained in 50% methanol, 1% acetic acid. The recRMLC band 
was excised from the membrane, rinsed in 10% methanol, dried, and se- 
quenced on a sequanator (477A; Applied Biosystems) on line with a model 
120A PTH analyzer. To determine the sequence of phosphorylated RMLC, 
thrombin-digested recRMLC was treated with MLCK (5/~g) and subjected 
to  urea-glycerol  gel  electrophoresis  to  resolve  phosphorylated  and  un- 
phosphorylated RMLC.  Protein was transferred to Problott, visualized by 
autoradiography, and the band corresponding to phosphorylated recRMLC 
was excised and sequenced as above. 
Enzymatic Assays 
ATPase. Purified myosin was treated with 5 mM CaCI2, 10 mM Tris-HCl, 
pH 8.0, 250 mM KCI, or varying concentrations of rabbit muscle aetin in 
the presence of 10 mM Tris-HCl, pH 7.6, 35 mM KCI, 5 mM MgCI2, 0.2 
mM CaC12 at room temperature. Reactions were initiated by the addition 
of 1 mM ATP containing ,~200,000 cpm//~l [3,32P]-iabeled  ATE Released 
phosphate was measured by the Kind, Otter, and Witman (1986) modifica- 
tion of the method of Follard and Koru (1973). To each 100-/zl reaction 250 
/zl 1:1 bertzene:isobntanol and 50/~120 mM silicotungstic acid/10 mM sul- 
furic acid was added and rapidly mixed. Following the addition of 50/~1 
1 mM KH2PO4 to serve as carrier phosphate, 40/~15 % ammonium molyb- 
date in 4  N  H2SO4 was added and vortexed for  10 s.  After allowing the 
mixture to partition for 5 rain, a 50-#1 aliquot of the upper organic phase 
was recovered and counted in Safety-Solve cocktail (Research Products In- 
ternational Corp., Mount Prospect, IL) in a scintillation counter (LS6800; 
Beckman Instrs.,  Carlsbad,  CA). 
MLCK.  Recombinant light chain or whole  myosin was  treated  with 
recombinant MLCK  (a generous  gift of J.  L.  Tan, J.  Smith,  and J.  A. 
Spudich, Stanford University) in 25 mM Triethunolamine, pH 7.5, 5 mM 
MgC12,  1 mg/ml BSA, 2 mM ATE 0.05 t~Ci/ml [3,32p]ATP, overnight at 
4°C (Tan and Spudich,  1991).  Reactions were precipitated by addition of 
equal  volume  10%  ice-cold trichloroacetic  acid,  the protein pellet  was 
resuspended in 2x SDS gel sample buffer (125 mM Tris-HC1, pH 6.8, 4% 
SDS,  10% B-mercaptoethanol, 20% glycerol), sonicated, neutralized with 
ammonium hydroxide fumes, and boiled before being run on PAGE. 
Morphological Analysis 
Cells  were processed  for 4',6'-diamidino 2-phenylindole (DAPI) fluores- 
cence and irnmunofluorescence according to Pollenz et al. (1992). A mouse 
cell line producing a mAb (396) directed against the Dictyostelium  myosin 
heavy chain (Pagh and Gerisch 1986) was a gift from Professor G. Gerisch. 
The cell culture supernatant was diluted 1:1 in phosphate buffered saline. 
Results 
Dictyostelium RMLC Is Phosphorylated on Serine 13 
by MLCK 
In vivo the Dictyostelium  RMLC is phosphorylated on serine 
(Berlot et al., 1987). There are 11 serines in the 161-amino 
acid polypeptide predicted from the eDNA sequence (Tafuri 
et al., 1989). Comparison with RMLC phosphorylation sites 
in other organisms suggested the Dictyostelium  RMLC phos- 
phorylation site was in the amino terminus of the molecule 
(Tafuri et al., 1989; Kobayashi et al. 1991). To determine the 
site of phosphorylation, we sequenced the amino terminus 
of the RMLC.  Because native RMLC purified from Dic- 
tyostelium cells  was  blocked  at  the  amino  terminus  we 
sequenced  recombinant  RMLC  purified  from  E.  coli. 
Alignment of the  sequences of E.  coli-expressed RMLC 
phosphorylated in vitro with cloned Dictyostelium MLCK 
(Tan and Spudich,  1991) and unphosphorylated recRMLC 
was  used  to  identify  the  phosphorylated  residue.  PTH- 
derivatives of phosphoserine are unstable during the acid 
cleavage step of  Edman degradation (Roach and Wang,  1991) 
and  are  read  as  a  blank  (Ikebe  et  al.,  1987).  Purified 
recRMLC was subjected to 26 cycles of PTH-amino acid se- 
quencing.  Unphosphorylated  RMLC  gave  the  sequence 
GSHMASTKRRLNREESSVVLGEEQVA. Fig.  1 A  shows 
traces of cycles 15 through 18 of the sequencing reactions 
performed on unphosphorylated recRMLC. The GSH resi- 
dues at the NH2 terminus are derived from the histidine tag 
used for purification. The remainder of the sequence corre- 
sponds to the sequence predicted from the RMLC eDNA 
(Tafuri et al.,  1989).  Phosphorylated recRMLC produced 
the same sequence except that no serine PTH-derivative was 
detected in cycle 16 (Fig.  1 B). The missing residue corre- 
sponds to Ser-13  of native RMLC. 
Oligonucleotide-directed mutagenesis  was  employed to 
convert the codon (TCA) for Serl3 of the cDNA to GCC 
which codes for a nonphosphorylatable Alal3 (Fig.  2 A). 
This mutation introduces a novel StuI restriction site into the 
cDNA. As a control for the amino acid substitution we also 
mutated Serl4  (TCT) to Alal4 (GCT).  This mutation in- 
troduces a novel PvulI restriction site into the cDNA. 
The S13A RMLC eDNA was expressed in E. coli  as a his- 
tagged fusion protein. Following purification the expressed 
RMLC were treated in vitro with MLCK (Fig. 2 B) and no 
phosphorylation was detected. The lowest limit of our de- 
tectability is 0.01 mol phosphage/mol RMLC. This result in- 
dicates that serl3 is the principal target for the cloned Dic- 
tyostelium MLCK. 
Generation of  Mutant Cells 
To  express  the  mutant  RMLC  cDNAs  in  Dictyostelium 
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Figure L Amino acid sequenc- 
ing  of  phosphorylated  and 
unphosphorylated  E.  coli- 
expressed RMLC  indentifies 
Serine-13 as the site of phos- 
phorylation  by  MLCK.  Re- 
combinant RMLC was treated 
with MLCK, resolved  by urea- 
glycerol  gel  electropboresis 
and subjected to PTH-amino 
acid sequencing as described 
in Materials and Methods. (,4) 
PTH-chromatogram  profiles 
of cycles 15 through 18 of un- 
phosphorylated RMLC corre- 
spond to the RMLC sequence 
predicted by the eDNA. (B) Detail of PTH-chromatogram profile of cycles 16 and 
17 of unphosphorylated (left) and phosphorylated (right) RMLC. Arrow indicates 
the position of serine which is absent in cycle 16 of the profile obtained for phos- 
phorylated RMLC, but which can be seen again in cycle 17. 
RMLC  null cells, we constructed a  Dicryostelium-expres- 
sion vector, pBORP (Fig. 3 A), which drives expression of 
inserted cDNAs from the constitutive actin 15 promoter and 
contains a neomycin resistance gene for selection of trans- 
formed  cells,  The  various  cDNAs  were  subcloned  into 
pBORP  to  produce  constructs  pBVN5131  (wild  type), 
pBVN5115 (S13A), and pBVNS133 (S14A). To allow detec- 
tion of the mutant protein when expressed in wild type cells 
(for experiments not shown), the cDNAs had been tagged at 
their 3' end with a  10-amino acid epitope for the myc on- 
cogene  (Stappenbeck  and  Green,  1992).  Three  different 
RMLC null cell lines were transformed separately with each 
of  the three expression constructs. At least three independent 
cell lines of each transformation were maintained and ana- 
A  11  12  13  14  '~5  16 
E  E  S  S  V  V 
Wild type  G  A  A  G  A  A  T  C  A  T  C  T  G  T  A  G  T  T 
E  E  A  S  V  V 
~13A  G  A  A  G  A  G(';  C  C  T  C  T  G  T  A  G  T  T 
E  E  S  A  V  V 
SI4A  QAAGAATCAGCTGTAGTT 
Figure 2.  Nucleotide changes in the  RMLC  eDNA encode an 
RMLC which cannot be phosphorylated by MLCK.  (A) The se- 
quence of the RMLC eDNA corresponding to codons 11 through 
16 and their respective single-letter amino acid codes are shown for 
the wild-type (top) Serine-13 to Alanine-13 substitution (middle) 
and  Serine-14 to  Alanine-14 substitution (bottom). Differences 
from wild type are italicized. (B) Autoradiograph of 12% SDS- 
PAGE of wild-type (lane 1 ) or S13A (lane 2) recRMLC expressed 
in E.  coli, purified, and treated in vitro with MLCK and [~32p]_ 
ATP. The MLCK is phosphorylated in both samples due to auto- 
phosphorylation. M, MLCK; R, recRMLC. 
lyzed.  The myc-tagged wild-type RMLC  expressing lines 
behaved in a similar fashion to the untransformed JH10 pa- 
rental cell line with respect to development and growth in 
suspension, except for a slightly slower growth rate which 
is typical of all of the transformed cell lines. 
RNA  from  cell  lines  transformed  with  the  constructs 
showed about 10-fold overexpression  of  RMLC mRNA (data 
not shown).  RMLC-myc fusion proteins were detected in 
transformed cell lysates by western immunoblot using  an 
anti-RMLC  monoclonal antibody  (IA2).  The myc-tagged 
RMLCs migrate with an apparent molecular mass of 19.5 kD 
(Fig. 3, B and C). The mutant RMLC copurifies with myosin 
(Fig. 4  C) confirming their association with the MHC. 
PCR was performed on DNA purified from transformed 
cell lines to amplify the RMLC coding sequence. The result- 
ing  products  were digested  with  StuI  or  PvulI  (data  not 
shown) to test for the presence of the novel restriction sites 
introduced by the  mutagenesis.  PeR products from cells 
transformed with pBVN5131 (WT) did not cut with StuI or 
PvulI.  Only  PCR  products  from  cells  transformed  with 
pBVN5115  (S13A)  cut with  StuI and  only PCR products 
from cells transformed with pBVN5133  (S14A)  cut with 
PvulI.  These results  confirmed the  introduced mutations 
were maintained in vivo. 
SI3A RMLC Myosin Is Not Phosphorylated 
When myosin purified from S13A and S14A transformed cell 
lines  was  treated  in  vitro  with  cloned  MLCK  (Tan  and 
Spudich, 1991), SI4A (Fig. 4 A, lane 2), but not S13A (lane 
/)  RMLC  was  phosphorylated.  This  result  confirms  the 
identification of S13A  as  the  site  of phosphorylation by 
cloned Dictyostelium MLCK. To determine if the SI3A and 
S14A RMLC are phosphorylated in vivo, cells were labeled 
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Figure 3. Lysates of RMLC null cells transformed with expression 
vector pBORP contain RMLC.  (.4) Map of Dictyostelium expres- 
sion vector pBORP. Neo  r  =  2-kb neomycin phosphotransferase 
cassette. A15P =  Actin 15 gene promoter where the ATP initiation 
codon has been mutated to a BamI-II site. AgI" =  Actin 8 gene ter- 
minator.  Amp  r  =  arnpicillin  resistance  cassette.  Restriction  en- 
zyme recognition sites: X, XbaI; B, BamHI; E, EcoRI. 5  x  105 
cells of parental strain JH10 (1), null El2 (2), and El2 transformed 
with wild type (3),  S13 A (4), or S14A (5) RMLC cDNAs were 
lysed  and  processed  for  PAGE as  described  in  Materials  and 
Methods. (B) Coomassie-stained  12% polyacrylamide gel, and (C) 
corresponding immunoblot reacted with the RMLC-specific mono- 
clonal antibody 1A2. No RMLC is detected in null line El2. S13A 
and S14A RMLC migrate at apparent molecular mass of 19.5 kD 
due to extra  10-arnino acid COOH-terminal  myc epitope tag. 
with 32p and myosin was immunoprecipitated using a heavy 
chain  specific antibody.  As  can be  seen in  Fig.  4  B,  the 
RMLC is labeled on both wild-type (lane/) and S14A (lane 
3) mutants, but not on the S13A mutant (lane 2).  Fig. 4  C 
shows the filter in Fig. 4 B, probed with an RMLC monoclo- 
hal antibody to confirm the presence of RMLC in all sam- 
ples.  The presence of similar levels of RMLC  in the  im- 
munoprecipitates from all three cell lines indicates that the 
mutant RMLC associate with the MHC with normal stoichi- 
ometry. These results clearly demonstrate that the S1 3A mu- 
tant is not phosphorylated to any significant extent in vivo. 
The absence of labeling indicates that serine 13 must be the 
predominant site of RMLC phosphorylation in vivo. 
Figure 4. Myosin carrying the S13A RMLC is not phosphorylated 
in vitro or in vivo. (A) Myosin was purified from cells, treated in 
vitro with MLCK and D,32P]ATP and analyzed by SDS-polyacryl- 
amide gel electrophoresis.  Autoradiogram  of in vitro 32p-labeled 
S13A (lane 1 ) or S14A (lane 2) myosin shows phosphorylation only 
in S14A RMLC.  (B) Myosin was immunoprecipitated  from 32p_ 
labeled cells expressing wild-type RMLC  (lane 1), S13A RMLC 
(lane  2)  and  S14A RMLC  (lane  3).  Following  separation  by 
SDS-polyacrylamide  gel electrophoresis, transfer to nitrocellulose 
and  autoradiography,  MHC phosphorylation  can be seen  in all 
three cell lines, and RMLC phosphorylation on wild-type and S14A 
RMLC, but not S13A RMLC.  (C) Immunoblot of the filter from 
B probed with anti-RMLC  monoclonal antibody  1AI0. 
$13A RMLC Myosin Exhibits Basal ATPase Activity 
The ATPase activities of myosins purified from the mutant 
and control cell lines were determined.  There was no sig- 
nificant difference between the  ATPase activity of myosin 
from wild-type cells or cells overexpressing wild-type myc- 
tagged RMLC (data not shown) indicating that neither the 
G418 drug selection nor the myc tag significantly affects my- 
osin enzymatic activity. S13A myosin had a calcium ATPase 
activity (V,= =  600 nmol Pi/min/mg) comparable to SI4A 
and wild-type myosin. However, S13A myosin had an actin- 
activated  ATPase  activity  (Vm~  =  20  nmol  Pi/min/mg) 
which was 30% that of S14A (Fig. 5) and wild-type myosin. 
This value for S13A  myosin is the same as that found for 
phosphatase-treated myosin in Griflith et al.  (1987).  S14A 
and wild-type myosin exhibit the same activity as untreated, 
partially phosphorylated myosin in Griflith et al.  (1987). 
$13A RMLC Corrects the Developmental 
Defect of  RMLC Null Cell Lines 
We next characterized the phenotypes of cell lines express- 
ing the modified RMLCs. The cells are motile and able to 
undergo cytokinesis on plastic and in shaking culture. When 
plated on lawns of Klebsiella aerogenes, S13A plaques ap- 
peared in four days, one day later than S14A plaques. Fruit- 
ing bodies developed in most plaques with a morphology and 
density  indistinguishable  from  wildtype  (Fig.  6).  Some 
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Figure 5.  Myosin containing  S13A RMLC  has  reduced  actin- 
activated MgATPase. Myosin purified from cells expressing wild 
type (triangle), S13A (diamond), and S14A (circle) RMLC were 
assayed for ATPase activity in the presence of 0-16 #M actin. 
plaques did not contain fruiting bodies.  Cells grown from 
non-developing plaques were G418 sensitive indicating they 
had lost the expression plasmid in the absence of drug selec- 
tion and reverted to the RMLC null phenotype. When trans- 
formants were plated on lawns of a G418 resistant E.  coli 
(Hughes et al.,  1992) on SM  agar containing G418  (100 
#g/ml) to maintain  selection throughout bacterial growth, 
normal fruiting bodies appeared in all plaques and contained 
G418-resistant spores. 
$13A Cells Exhibit Normal Myosin Localization 
Cells were processed for indirect immunofluorescence and 
stained with an anti-MHC monoclonai antibody (396).  In 
RMLC null cells, myosin localization is affected in both sub- 
strate and suspension cultured cells (Chen et al.,  1994). In 
suspension cultured RMLC null cells myosin is observed to 
have a primarily endosomal localization in contrast to the 
primarily cortical localization seen in wildtype cells. When 
RMLC null cells were grown on a solid substrate myosin was 
seen in  a  normal cortical localization or in  intense  spots 
generally found near the posterior cortex. In contrast, myo- 
sin in the S13A and S14A mutant cells showed a pattern of 
localization similar to that  seen in  wild-type transformed 
cells (Fig. 7). Thus, expression of  the S13A and S14A mutant 
light chains corrected the defect in myosin localization ob- 
served in the RMLC null cells (Chen et al.,  1994). 
$13A RMLC Corrects the Cytokinesis Defect of  RMLC 
Null Cells 
When RMLC null cells are grown in suspension they be- 
come large and multinucleate due to a defect in cytokinesis 
(Fig. 8 A). Null cells transformed with wild type, S13A, and 
Figure 6.  RMLC null cells transformed  with S13A and S14A RMLC develop normally.  Cells were plated on K. aerogenes and allowed 
to develop.  (A) RMLC null cells. (B) RMLC null cells transformed  with wild-type RMLC. (C) RMLC null cells transformed  with S13A 
RMLC.  (D) RMLC null cells transformed  with S14A RMLC. Only null cells do not complete development. Bar,  1 mm. 
The Journal of Cell Biology, Volume 127, 1994  1950 Figure 7. Distribution of myosin in control and mutant ceils. Paired phase (a-d) and anti-MHC indirect immunofluorescence  (e-h) pho- 
tomicrographs. Cells of wild type (a and e), RMLC null El2 transformed with wild-type RMLC (b and f), RMLC null E2 transformed 
with S13A RMLC (c and g), and RMLC null El2 transformed with S14A RMLC (d and h). Immunofluorescence  of all cells exhibited 
myosin localization in cortical regions and the contractile ring of dividing cells. RMLC null El2 transformed with S13A RMLC exhibit 
more cytoplasmic myosin localization than seen in the other cell types. Bar, 10/xm. 
S14A remain mostly mononucleate in suspension (Fig. 8, B, 
C, and D). Null cells transformed with wild type, S13A, and 
S14A grow with a doubling time of 18 h (Fig. 9). There was 
a reduction in growth rate of 86 % compared to parental cells 
of strain JH10 which may be due to the presence of the G418 
selection drug. Alternatively, the added metabolic burden of 
high levels of ectopic expression of RMLC could contribute 
to decreased growth rate. 
Discussion 
We have identified the site of  phosphorylation on the RMLC 
of Dictyostelium  myosin and used site directed mutagenesis 
to replace the phosphorylated serine with a non-phosphor- 
ylatable alanine. When this mutant light chain is expressed 
in an RMLC null cell line created by targeted disruption of 
the RMLC gene, the mutant RMLC corrects the phenotypic 
defects of the mlcR- cells as  well as does  expression of 
wild-type RMLC. By immunoprecipitation of myosin from 
32p-labeled cells, we were unable to detect phosphorylation 
of the mutant RMLC. Although the mutant myosin appears 
capable of performing the normal cellular functions of myo- 
sin,  it has a  significantly reduced actin-activated ATPase, 
comparable to that observed in wild-type myosin dephos- 
phorylated by phosphatase treatment. These results suggest 
that the phosphorylation of  the RMLC is not required for cel- 
lular functions including cytokinesis and cell movements re- 
quired for multiceUular morphogenesis. 
Several  lines of evidence have suggested the importance 
of RMLC phosphorylation.  First,  phosphorylation of the 
RMLC in smooth muscle and vertebrate nonmuscle systems 
is required for significant levels of actin-activated ATPase 
activity (Kamm and Stull,  1985; Trybus,  1989;  Tan et al., 
1992).  Second, RMLC phosphorylation has been shown to 
regulate the actin-activated ATPase activity of myosins from 
a variety of sources, including Dictyostelium.  Phosphoryla- 
tion also has been shown to regulate motor function as as- 
sayed by the movement of actin filaments in vitro (Griflith 
et al., 1987; Uyeda and Spudich, 1993; Ruppel et al., 1994). 
Third, the phosphorylation of Dictyostelium RMLC is tightly 
regulated during the aggregation stage of development. Ber- 
lot et al.  (1985) have  shown that phosphorylation of the 
RMLC increases  within 20  s  following binding of cyclic 
AMP to  the  cell  surface cAMP receptor  responsible  for 
mediating chemotaxis. The level of RMLC phosphorylation 
peaks soon thereafter and declines to prestimulation levels 
by 90-120 s.  During this period,  30 s to 2 min following 
chemotactic stimulation, Dictyostelium  cells exhibit the so- 
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mostly mononueleate in suspension. Cells were grown in suspen- 
sion for 3 d and then fixed, stained with DAPI, and scored for num- 
ber of nuclei per cell.  (A) Paired phase (a-d) and DAPI fluores- 
cence (e-h) photomicrographs. Cells of RMLC null cell El2 (a and 
e), RMLC null El2 transformed with wild-type RMLC (b and f), 
RMLC  null  El2 transformed  with  SI3A RMLC (c and g),  and 
RMLC  null  El2 transformed  with S14A RMLC  (d and h).  (B) 
Histogram showing the distribution  of the number  of nuclei per 
cell. At least 200 cells of each cell type on two separate coverslips 
were scored. The average percentage of cells in each category is 
presented. A majority of null cells have greater than six nuclei per 
cell, whereas the other cell lines were mostly mono- or binucleate. 
i, RMLC  null;  ~2, wild-type cDNA;  O,  S13A eDNA;  r~, Sl4A 
cDNA.  Bar, 30 t~m. 
called cringe  response,  in  which  they round  up and  stop 
moving.  Fukui  and colleagues (Yumura and Fukui,  1985; 
Nachmias et al.,  1989) have also shown that the pattern of 
myosin staining changes from a predominantly endoplasmic 
localization  to  a  primarily  cortical  one  in  response  to 
chemoattractant. Finally, Dictyostelium  expresses a myosin 
light  chain  kinase  which  is  highly  specific  for  the  Dic- 
tyostelium  RMLC  (Griflith  ~t  al.,  1987).  Taken together, 
these  observations  are  consistent  with  a  role  for  RMLC 
phosphorylation in development. 
Berlot et ai. (1987) demonstrated that the RMLC is phos- 
phorylated on  serine.  Based  on  sequence  homology with 
other RMLCs, it was previously suggested that S14 was the 
probable phosphorylation site (Tafuri et al.,  1989;  see also 
Tan et al., 1992, Fig. 3). Based on considerations of the local 
sequence environment surrounding the phosphorylation site, 
Kobayashi  et  al.  (1991)  proposed  that  the  Dictyostelium 
RMLC  was phosphorylated at  S13. By  comparing amino 
acid sequence of E. coli-expressed  RMLC before and after 
treatment with cloned Dictyostelium MLCK, we have deter- 
mined that S13 is phosphorylated by cloned MLCK in vitro. 
The identification of the  MLCK phosphorylation site was 
confirmed by our observation that a  recombinant RMLC, 
carrying a  serine  13 to alanine mutation,  expressed in E. 
coli, was no longer phosphorylated to any significant degree 
following treatment with purified Dictyostelium  MLCK. 
Several studies have shown that the level of phosphoryla- 
tion regulates the actin-activated ATPase and the ability of 
Dictyostelium myosin to produce ATP dependent movement 
of actin filaments in vitro (Griflith et al.,  1987;  Uyeda and 
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Figure 9. RMLC null cells transformed with S13A RMLC grow in 
suspension with normal doubling times. Cells were inoculated in 
flasks and shaken for 5 d. Aliquots were counted on each day and 
plotted as 106 cells/ml. RMLC null cells double only twice in 5 d, 
whereas the other cell lines exhibit exponential growth and satu- 
ration. 
Spudich,  1993;  Ruppel et al.,  1994).  When purified from 
vegetative Dictyostelium cells, the RMLC typically carries 
about 0.3 mol phosphate per mole of RMLC polypeptide. In 
contrast, myosin purified from ruleR- cells expressing S13A 
RMLC showed no light chain phosphorylation. Both immu- 
noprecipitation of myosin from 32p-labeled cells and urea- 
glycerol gel analysis of purified myosin (data not shown) 
showed no evidence of phosphorylation on S13A RMLC. 
Myosin carrying the S13A RMLC exhibited levels of calcium 
ATPase comparable to wild type, although the level of actin- 
activated ATPase activity was only 25-30% that of wild-type 
type. Phosphatase treated myosin carrying less than 0.01 mol 
phosphate per mole of RMLC showed ATPase activities of 
,,020  nmol/min/mg protein  (Griffith et al.,  1987),  corre- 
sponding to a  turnover rate of ,'~0.09 per s.  S13A myosin 
purified from vegetative cells had comparable levels of  actin- 
activated ATPase activity (also 0.09  per s).  This level  of 
actin-activated ATPase activity is also in the range obtained 
by steady state measurements of dephosphorylated smooth 
muscle myosin (Sellers et al., 1981; Trybus, 1989).  Thus it 
appears that the S13A RMLC mutation produced the antici- 
pated result:  myosin with actin-activated ATPase activity 
comparable to unphosphorylated myosin. However, despite 
the reduced actin-activated ATPase, the S13A RMLC myosin 
had  sufficient function in  vivo  to  rescue  the  phenotypic 
defects of the RMLC null cells. RMLC null cells expressing 
the S13A mutant myosin grew in suspension with a doubling 
time comparable to cells rescued by wild-type RMLC, and 
progressed normally through the aggregation and multicellu- 
lar stages of Dictyostelium development. 
It  has  been  proposed  that  the  RMLC  can  be  phos- 
phorylated by kinases other than the MLCK, including both 
PKC and p34  ~2 kinase. The sequence of the RMLC sug- 
gests there are potential sites for phosphorylation by PKC at 
Ser-3  or  Thr-4  and by p34  cdc2 kinase at Ser-3.  Since the 
S13A mutant shows no detectable phosphorylation, it seems 
unlikely that a significant portion of the RMLC in growing 
cells is phosphorylated at one or more of these sites.  How- 
ever,  a  cell  cycle-dependent phosphorylation such as has 
been suggested by Satterwhite et al.  (1992) may not have 
been detectable in our experiments. Assuming the cell popu- 
lation  is  randomly distributed  throughout  the  cell  cycle 
(which is a minimum of 8 h long) and the period of mitosis 
where the RMLC would be phosphorylated is shorter than 
10-15 rain, the phosphorylation would be below our limit of 
detection.  There has been concern that the characterized 
Dictyostelium MLCK may not be the only kinase capable of 
phosphorylating the RMLC (Silveira, L. A., J. A. Smith, 
and J. A. Spudich, personal communication). Our inability 
to detect phosphorylation on the S13A mutant suggests that 
regardless of the kinase responsible for phosphorylation, S13 
must  be  the  predominant  phosphorylation  site  on  Dic- 
tyostelium RMLC. 
There have been many studies demonstrating the impor- 
tance of  RMLC phosphorylation for the biochemical proper- 
ties of myosin thought to correlate with in vivo contractile 
activity. Many of these studies have used desensitized scal- 
lop myosin hybrids reconstituted with foreign light chains 
(Kendrick-Jones et al.,  1976;  Sellers et al., 1980;  Reinach 
et al., 1986), or myosin from which RMLC was removed or 
exchanged (Lowey et al., 1993; Trybus and Chatman, 1993; 
Trybus et al.,  1994).  These experiments and others have 
shown that phosphorylation increases  the  actin activated 
ATPase of smooth muscle and non-muscle myosins, includ- 
ing Dictyostelium  myosin. In addition, phosphorylation is 
coupled to the initiation of contraction in smooth muscle 
(Hartshorne and Siemankowski, 1981) and has been shown 
to promote a conformational change that converts folded my- 
osin monomers into an extended form that is assembly com- 
petent. 
Given this wealth of in vitro data it seems surprising that 
a phosphorylation site deficient RMLC functions sufficiently 
well to complement all of the tested phenotypic defects of a 
RMLC null mutant. These results question the significance 
of RMLC phosphorylation in vivo. While it is possible that 
Dictyostelium  is  unusual  with  regard  to  the  function of 
RMLC phosphorylation, it is comparable to other myosins 
in structure (Warrick et al.,  1986;  Pasternak et al.,  1989; 
Schroder et al.,  1993),  and in the levels of ATPase activity 
and motor activity as  indicated by rates  of movement it 
produces in in vitro motility assays (Griffith et al.,  1987; 
Uyeda and Spudich,  1993;  Ruppel et al.,  1994).  Dictyo- 
stelium myosin may be unusual in that filament assembly is 
regulated by myosin heavy chain phosphorylation (Kuczmar- 
ski and Spudich, 1980; Egelhoff et al.,  1993),  and that the 
myosin light chain kinase is calcium independent (Griffith et 
al.,  1987; Tan and Spudich, 1990).  In addition, the magni- 
tude of phosphorylation dependent enhancement of actin ac- 
tivated ATPase activity may be  somewhat lower for Dic- 
tyostelium myosin than for smooth muscle myosin. However, 
these measurements have been of steady state activity, and 
may result in an underestimation of the phosphorylation- 
dependent activation of Dictyostelium myosin as has been 
shown for smooth muscle myosin steady-state measurements 
(Sellers, 1985). Alternatively these results may suggest that 
RMLC phosphorylation plays a more subtle role in regula- 
tion than would be detected by the relatively crude assays of 
growth rate and development timing and competence. For 
example,  phosphorylation  could  make  cytokinesis  more 
efficient by 5 %, producing a 5 % increase in growth rate, 
which would be difficult to document, but which might lead 
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taining this regulatory process. In this light it is interesting 
to note the recent report by Uyeda and Spudich (1993) that 
a  mutant  Dictyostelium  myosin  heavy  chain  lacking  the 
RMLC-binding  domain  complements  most of the pheno- 
typic defects of a myosin heavy chain null mutant.  This mu- 
tant  myosin has  somewhat increased ATPase activity  and 
produced normal rates of actin filament movement using an 
in vitro motility assay.  These results provide independent 
support for the hypothesis that the regulatory role of RMLC 
phosphorylation in Dictyostelium is not essential. However, 
the Uyeda and Spudich results taken together with our report 
that an mlcR- cell exhibits many  of the defects of mhcA- 
cells (Chen et al.,  1994), make it likely that some function 
provided by the RMLC, perhaps a subtle modulation of func- 
tion,  provides  sufficient selective advantage  to  assure the 
maintenance  of the RMLC  and  myosin light chain kinase 
through  evolution. 
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